A sharp increase in staphylococcal scalded skin syndrome (SSSS) cases has been recorded in our settings since 2015, with 31 cases having been documented during the period 2014-2017. The molecular investigation of strains from the above period showed the emergence of a methicillin-susceptible, mupirocin-and fusidic acid-resistant Staphyloccocus aureus clone that belongs to the ST121 complex and carries both epidermolysin (eta/etb) genes. We concluded that the SSSS caused by the newly emerged, highly virulent community-associated-methicillin sensitive S. aureus strains that have been encountered lately is more severe than impetigo. Physicians should be aware of the probability of SSSS epidemics from strains that are resistant to mupirocin and fusidic acid, which have been used irrationally and excessively.
INTRODUCTION
Staphylococcal scalded skin syndrome (SSSS) is a rare vesiculating skin condition that is mostly seen in infants and young children and is rarely observed in adults. It appears as a form of localized bullous impetigo or in a generalized form. This clinical manifestation is caused by epidermolysins A or B (ETA/ETB) secreted by certain strains of Staphylococcus aureus [1] . According to the literature, most cases of SSSS are connected to community-associated methicillinsensitive S. aureus (CA-MSSA) strains in various countries [2, 3] . In our settings, the disease was sporadic up to 2014, with one case annually, but from 2014 onwards an increase in the number of SSSS cases was noted, in parallel with the increase in impetigo cases during the same period. The aim of the current study was to investigate the clinical, microbiological and molecular characteristics of SSSS cases isolated from clinical samples from 1 January 2012 to 31 December 2017.
METHODS
The P. and A. Kyriakou Children's hospital in Athens is a tertiary care referral centre accommodating 400 beds. Each year the hospital receives 25 000-27 000 admissions and about 80 000 outpatient visits in the emergency department. All SSSS cases were reviewed retrospectively and epidemiological data were collected through patient file reviewing. The study was approved by the hospital's Ethics Committee. Staphylococcal strains isolated either from the specific skin lesions or colonizing ones isolated from nasal or skin fold cultures in patients with SSSS were analysed.
Identification of the pathogen was performed with standard culture methods and susceptibility testing was performed using the disc diffusion method according to Clinical and Laboratory Standards Institute (CLSI) guidelines [4] , except for fusidic acid, for which the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines were used [5] . Testing for inducible (macrolide-lincosamide-streptogramin B inducible; MLSBi) and constitutive (macrolide-lincosamide-streptogramin B constitutive; MLSBc) lincosamide resistance was performed by D-test. Low-level resistance (LLR) and high-level resistance (HLR) to mupirocin were screened using 5 µg and 200 µg discs, respectively. Isolates with no zone inhibition to both discs were considered to have HLR [6] . All mupirocin-resistant strains were kept at À80 C in skim milk. Among them, 11 strains recovered from SSSS cases during 2014-2016 were available for molecular analysis performed at the National Reference Laboratory for staphylococci.
Genes encoding HLR to mupirocin (mupA), resistance to fusidic acid (fusB) and resistance to macrolides and lincosamides (ermC, ermA), Panton-Valentine leukocidin (lukS/ lukF-PV), exfoliative toxins ETA and ETB (eta, etb), arginine catabolic mobile element (arcA) and fibronectin-binding protein A (fnbA) were investigated by polymerase chain reaction (PCR) [7] . The PCR products were analysed by electrophoresis on agarose 1 % w/v gels. The primers used, PCR conditions, and positive controls for PCR, pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) in all 11 strains were as described elsewhere (http:// saureus.beta.mlst.net) [8, 9] . Counts and percentages were reported for categorical variables and the median and the interquartile range (IQR: 25th-75th percentile) for continuous variables with non-symmetric distribution.
RESULTS
From 2010 to 2017 a total of 34 SSSS cases were recorded among otherwise healthy children (17 boys, age range 12 days to 7 years, median age 26 months).
No cases of SSSS were recorded in 2010 and 2011, and there was one case annually from 2012 to 2014, followed by a sharp increase in the number of cases in 2015 (n=6), 2016 (n=14) and 2017 (n=11) (Fig. 1) . Half of the cases were recorded during the summer months (June to September). The observed increase in the number of cases coincided with the emergence of mupirocin resistance. Specifically, both strains isolated in 2012 and 2013 were mupirocin-and fusidic acid-susceptible, while the strains isolated between 2014 and 2017 were all mupirocin-and fusidic acid-resistant (Fig. 1) . All strains were susceptible to methicillin and resistant to penicillin, while 7/34 (20.6 %) were constitutively resistant to clindamycin (6/30 among the mupirocinresistant). All strains were susceptible to trimethoprim/ sulfamethoxazole.
Thirty-one out of 34 patients with SSSS were colonized with S. aureus strains of the same phenotype (resistant to mupirocin and fusidic acid) from nares and/or skin folds. For the remaining three, colonization of the patients was not documented, but the specific strain was isolated from close relatives caring for the child.
Parenteral antibiotic therapy with oxacillin or amoxicillin/ clavulanic acid and/or clindamycin was proven to be effective and all patients experienced a full recovery. A 2.5-yearold boy was admitted for 5 days to the paediatric intensive care unit (PICU) due to an extended spread (>15 % of body surface area) of lesions. Among the patients, two were neonates (12 and 16 days of age) and one had already been admitted to the neonatal intensive care unit (NICU) due to prematurity.
The molecular analysis of the 11 available S. aureus strains showed that all were mupA-positive, fusB-positive, lukS/ lukF-positive, positive for both epidermolysin (eta/etb) genes, and fnbA-positive. Three clindamycin-resistant strains were ermC-positive. None were found to be positive for the arcA/ACME operon. With respect to PFGE genotyping, all 11 strains belonged to 1 common pulsotype (pulsotype 1) and to subtypes 1a (10 strains) and 1c (1 strain). All strains belonged to agrIV. These strains were classified by MLST into ST121 and belonged to CC121.
DISCUSSION
In this report, we describe a sharp increase in the number of SSSS cases in our settings from 2015 and onwards caused by an emerging community-associated MSSA clone that is resistant to both mupirocin and fusidic acid and also carries the eta/etb genes encoding epidermolysins. The LukS/LukF-PV and eta genes are located on phages, whereas etb is located on a plasmid. As recently reported by our centre, this clone is mainly associated with superficial skin infections such as impetigo [8] . Highly discriminatory methods such as PFGE allow for the deep characterization and understanding of bacterial isolates, since the genome sequence of different SA isolates may differ by up to 22 % among strains. However, the staphylococcal isolates associated with SSSS were investigated with molecular typing and were shown to also belong to the ST121 clone. This newly emerged clone is closely related to the European epidemic fusidic acid-resistant impetigo clone, EEFIC (ST123, CC121), which was first described around 2000 and has been described in various reports from the United Kingdom, Ireland, France and Scandinavian countries [10, 11] . The presence of agrIV allele, eta (and in a large proportion etb) and fusB is highly indicative of the aforementioned clone. The last report on the ST123 clone was from Norway in 2014, showing evidence of extinction since 2012 [12] . ST121 is presumed to be the ancestral type of CC121 and ST123 is a double-locus variant [13] . ST121 is a well-known virulent clone that has been reported in various countries and is almost ubiquitously agrIV-and mecA-negative (MSSA). It colonizes the nares of asymptomatic carriers. Before 2012 it had been reported in Germany, Spain, Portugal and Russia, whereas after 2012 most epidemiological data show the expansion of the EEFIC clone [13] . It has been shown, though, that the EEFIC clone has been present in Germany and the Czech Republic since at least 2007 and 2005, respectively [14] .
The age of the children affected (median age 26 months) confirms that SSSS is predominantly a disease of infants and younger children. It was shown previously that there is a significant difference in the age at the onset of symptoms between SSSS cases [mean, 33 months; median, 30 months (interquartile range, IQR, 16 to 48 months)] and impetigo cases [mean, 73 months; median, 72 months (IQR, 36 to 105 months); P<0.001] [8] . In addition, similar to other staphylococcal skin infections, SSSS occurred mostly during the summer and autumn months.
Diagnosing SSSS is mostly a clinical task, based on findings of tender erythroderma, bullae and desquamation, particularly at friction zones, a scalded skin appearance, perioral crustal, often a positive Nikolsky sign and the absence of mucosal involvement. It must be differentiated clinically from similar blistering and exfoliating disorders, such as bullous impetigo, epidermolysis bullosa, epidermolytic hyperkeratosis, pemphigus, drug eruption, erythema multiforme and drug-associated epidermal necrolysis (StevensJohnson) [1] . Intact bullae in SSSS are always sterile, unlike those of bullous impetigo, since this condition is toxinmediated. However, cultures should be obtained from all possibly infected sites as well as blood and the nares and skin folds to document S. aureus carriage.
In the past decade, the increasing number of MRSA worldwide has resulted in greater use of mupirocin for decolonization purposes. The increasing, indiscriminate and repetitive use of mupirocin may have contributed to the development of resistance and the emergence of this newly identified toxinogenic clone, which is associated with new morbidity, namely the profound increase of SSSS. Since innocent nasal colonization is the first step before a staphylococcal infection appears and topical treatment is currently of no use for eradication in carriers, pathogenic strains persist for longer periods among children, facilitating child-tochild and interfamilial transmission. Staphylococcal scalded skin syndrome is a potentially severe disease, although it is caused by methicillin-susceptible S. aureus strains. Physicians taking care of children need to be aware of this clinical entity so that they can diagnose it in a timely manner and treat it promptly.
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